- Recce Pharmaceuticals (RCE) secures a US patent for its antibiotic product RECCE 327 and antiviral formulation RECCE 529
- This is the company's fourth of five patents to be granted, following China, Japan and Europe, with only Australia remaining
- The US is considered the largest and most influential pharmaceutical market in the world, valued at US$339 billion (around A$461 billion)
Read the Full Article on The Market Herald here
- Forums
- ASX - By Stock
- RCE
- Recce Pharmaceuticals (ASX:RCE) granted US patent
Recce Pharmaceuticals (ASX:RCE) granted US patent
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
53.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $108.0M |
Open | High | Low | Value | Volume |
55.0¢ | 55.0¢ | 53.0¢ | $1.769K | 3.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 708 | 53.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.5¢ | 14744 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 708 | 0.535 |
2 | 15913 | 0.530 |
1 | 10000 | 0.520 |
1 | 7181 | 0.515 |
2 | 7000 | 0.510 |
Price($) | Vol. | No. |
---|---|---|
0.545 | 14744 | 1 |
0.550 | 29999 | 2 |
0.560 | 68070 | 5 |
0.570 | 47000 | 1 |
0.575 | 1393 | 1 |
Last trade - 10.18am 18/04/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online